SC
LLY icon

Sculptor Capital’s Eli Lilly LLY Stock Holding History

Sculptor Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100,000
Closed -$13M – 290
2019
Q1 		$13M Buy
+100,000
New +$12.2M 0.08% 72
2015
Q1 		– Sell
-2,200
Closed -$152K – 615
2014
Q4 		$152K Sell
2,200
-3,400
-61% -$229K ﹤0.01% 718
2014
Q3 		$363K Sell
5,600
-5,000
-47% -$317K ﹤0.01% 715
2014
Q2 		$659K Sell
10,600
-7,200
-40% -$430K ﹤0.01% 695
2014
Q1 		$1.05M Sell
17,800
-181,200
-91% -$10.1M ﹤0.01% 646
2013
Q4 		$10.1M Sell
199,000
-119,800
-38% -$6M 0.03% 453
2013
Q3 		$16M Sell
318,800
-7,600
-2% -$398K 0.05% 379
2013
Q2 		$16M Buy
+326,400
New +$17.8M 0.05% 355

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sculptor Capital's LLY Position: Q3 2022 in Review

Sculptor Capital sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 19,222 shares — an estimated $6.23M sold.

Sculptor Capital first reported a position in LLY in Q2 2013 and held it in 10 quarters. The position peaked at $41.3M in Q1 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Sculptor Capital reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • Sculptor Capital sold 19,222 Eli Lilly shares in Q3 2022, an estimated $6.23M.
  • Sculptor Capital first reported a position in Eli Lilly in Q2 2013 and held it in 10 quarters.
  • Sculptor Capital's Eli Lilly position peaked at $41.3M in Q1 2022.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.